Cargando…
Molecular Markers of Tumor Progression in Melanoma
Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709934/ https://www.ncbi.nlm.nih.gov/pubmed/19949544 http://dx.doi.org/10.2174/138920209788488526 |
_version_ | 1782169340999630848 |
---|---|
author | Rother, Joshua Jones, Dan |
author_facet | Rother, Joshua Jones, Dan |
author_sort | Rother, Joshua |
collection | PubMed |
description | Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array studies, genomic profiling, and genetic models. We focus on the role of tumor suppressors involved in cell cycle function, DNA repair, and genome maintenance. Highlighted are the roles of loss of p16 in promoting neoplasia in cooperation with deregulated MAPK signaling, and the role of loss of the RASSF1A protein in promoting chromosomal instability. The interactions between point mutation in growth signaling molecules and epigenetic changes in genes involved in DNA repair and cell division are discussed. |
format | Text |
id | pubmed-2709934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Bentham Science Publishers Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-27099342009-12-01 Molecular Markers of Tumor Progression in Melanoma Rother, Joshua Jones, Dan Curr Genomics Article Malignant melanoma represents one of the most aggressive malignancies but outcome is highly variable with early tumor lesions having an excellent prognosis following resection. We review here the data on identification of genes involved in the progression of melanoma as a result of expression array studies, genomic profiling, and genetic models. We focus on the role of tumor suppressors involved in cell cycle function, DNA repair, and genome maintenance. Highlighted are the roles of loss of p16 in promoting neoplasia in cooperation with deregulated MAPK signaling, and the role of loss of the RASSF1A protein in promoting chromosomal instability. The interactions between point mutation in growth signaling molecules and epigenetic changes in genes involved in DNA repair and cell division are discussed. Bentham Science Publishers Ltd. 2009-06 /pmc/articles/PMC2709934/ /pubmed/19949544 http://dx.doi.org/10.2174/138920209788488526 Text en ©2009 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Rother, Joshua Jones, Dan Molecular Markers of Tumor Progression in Melanoma |
title | Molecular Markers of Tumor Progression in Melanoma |
title_full | Molecular Markers of Tumor Progression in Melanoma |
title_fullStr | Molecular Markers of Tumor Progression in Melanoma |
title_full_unstemmed | Molecular Markers of Tumor Progression in Melanoma |
title_short | Molecular Markers of Tumor Progression in Melanoma |
title_sort | molecular markers of tumor progression in melanoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709934/ https://www.ncbi.nlm.nih.gov/pubmed/19949544 http://dx.doi.org/10.2174/138920209788488526 |
work_keys_str_mv | AT rotherjoshua molecularmarkersoftumorprogressioninmelanoma AT jonesdan molecularmarkersoftumorprogressioninmelanoma |